Global Nuclear Medicine-Radiopharmaceuticals Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Nuclear Medicines are primarily drugs that contain radioactive elements for radionuclide-emitting ionizing radiations. Their core application lies in the diagnosis and treatment of various diseases that conventional medicines fail to achieve. Radiopharmaceuticals are unique as they are used to directly target specific organs sites in the body where the drug can emit radiations. These radiations are then captured by gamma cameras placed in proximity of the patient. The radiation dose in these pharmaceuticals is kept as low as possible to avoid the side effects of radiation exposure. The Nuclear Medicine-Radiopharmaceuticals market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Nuclear Medicine-Radiopharmaceuticals market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Nuclear Medicine-Radiopharmaceuticals Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Nuclear Medicine-Radiopharmaceuticals market are: Sigma Aldrich Corporation Jubilant Pharma Medtronic Plc GE Healthcare Eczacibasi-Monrol Nuclear Products Cardinal Health, Inc Bayer AG Lantheus Medical Imaging, Inc Advanced Accelerator Applications S.A. Iba Molecular Bracco Imaging S.P.A Siemens Healthcare Nordien, Inc Nordion, Inc Mallinckrodt PLC Most important types of Nuclear Medicine-Radiopharmaceuticals products covered in this report are: Diagnostic Medicine Therapeutic Medicine Most widely used downstream fields of Nuclear Medicine-Radiopharmaceuticals market covered in this report are: SPECT PET Therapeutic Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.